NCT04322630View on ClinicalTrials.gov

Mer-TK in Human Cardiac Cells

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Myocardial InflammationMyocardial Infarction
Interventions
OTHER

Change in Soluble MER Concentration

Measuring change in soluble MER Concentration post compared to pre bypass for each patient.

Trial Locations (1)

60611

Ann & Robert H Lurie Children's Hopsital, Chicago

All Listed Sponsors
lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT04322630 - Mer-TK in Human Cardiac Cells | Biotech Hunter | Biotech Hunter